The Open UniversitySkip to content
 

Exploiting the Mitochondrial Fox 03A/SIRT3 Complex in Cancer Therapy

Celestini, Valentina (2019). Exploiting the Mitochondrial Fox 03A/SIRT3 Complex in Cancer Therapy. PhD thesis. The Open University.

Full text available as:
[img]
Preview
PDF (Version of Record) - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
Download (8MB) | Preview
Google Scholar: Look up in Google Scholar

Abstract

As other many transcription factors, FoxO family members are involved in several cellular processes, including proliferation, apoptosis, stress resistance and metabolism. Their activity is finely regulated by phosphorylation, acetylation and ubiquitination events, which are modulated by multiple signalling pathways. Through the combination of specific post-translational modifications, composing a unique “molecular FoxO code”, FoxO proteins modulate different physiological processes and pathological events, such as cancer.

Previously, a mitochondrial arm of the AMPK-FoxO3A axis, representing a mechanism sustaining the energy metabolism upon nutrient shortage, has been revealed in normal cells and tissues. Data collected during this project show that in metabolically stressed cancer cells, FoxO3A is recruited to the mitochondria through activation of MEK/ERK and AMPK pathways. These kinases phosphorylate Serine 12 and 30, respectively, on the FoxO3A N-terminal domain, which is required for FoxO3A recruitment to the mitochondrial surface. Upon translocation into the organelle, the N-terminal domain is cleaved by processing peptidases, and the released product reaches the mitochondrial matrix. Here, the cleaved form of FoxO3A binds to the mitochondrial DNA (mtDNA) and activates the transcription of the mitochondrial genes, to support mitochondrial metabolism and cell survival. Interestingly, it seems to be a cancer-specific mechanism. Moreover, in cancer cells treated with chemotherapeutic agents, accumulation of FoxO3A into the mitochondria promotes their survival in a MEK/ERK-dependent manner. Importantly, mitochondrial FoxO3A is required for apoptosis induction by Metformin. Elucidation of FoxO3A mitochondrial versus nuclear functions in cancer cell homeostasis might help devise novel therapeutic strategies to disable FoxO3A pro-survival activity selectively.

Item Type: Thesis (PhD)
Copyright Holders: 2018 The Author
Keywords: cancer; FOXO3A; mitochondria; SIRT3; transcription factors; forkhead transcription factors
Academic Unit/School: Faculty of Science, Technology, Engineering and Mathematics (STEM)
Associated Research Centre: IRCCS Istituto di Ricerche Farmacologiche Mario Negri
Item ID: 58897
Depositing User: Valentina Celestini
Date Deposited: 06 Mar 2019 13:24
Last Modified: 24 Jan 2020 03:06
URI: http://oro.open.ac.uk/id/eprint/58897
Share this page:

Download history for this item

These details should be considered as only a guide to the number of downloads performed manually. Algorithmic methods have been applied in an attempt to remove automated downloads from the displayed statistics but no guarantee can be made as to the accuracy of the figures.

Actions (login may be required)

Policies | Disclaimer

© The Open University   contact the OU